Clinical trial
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
NCT04434586 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
- Lead sponsor
- University Hospital, Lille
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 16, 2020
- Completion date
- June 30, 2026
- Enrollment
- 166 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
claudication, ischemic leg, superficial femoral artery stenosis